Womens presenting with regular menstrual migraine treated with triptans will be included in the study. Self-measure of ICP will be performed outside and during menstrual migraine attacks. The potential variations will be compared to the measures done on matched healthy women outside and during menses.
Age
18–50
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
18 to 50 non menopausal women
Menstrual migraine
Using a triptan as usual treatment to relieve attacks
Usual triptan efficacy although recurrence is possible
You may not be if
Disease of the ear
Intracranial hypertension
Chronic daily headache
Use of topiramate or acetazolamide
Triptans used more than 10 days/month
Analgesic drug used more than 15 days/month
Uncontrolled high blood pressure
BMI \>30
Ongoing allergic rhinitis or flu
Clareo Health | Intracranial Pressure During Migraine
